Q4 EPS Forecast for Amprius Technologies Lifted by Analyst

Amprius Technologies, Inc. (NYSE:AMPXFree Report) – Analysts at Northland Securities lifted their Q4 2026 earnings estimates for shares of Amprius Technologies in a report released on Monday, March 9th. Northland Securities analyst E. Jackson now forecasts that the company will post earnings per share of $0.01 for the quarter, up from their prior forecast of ($0.01). The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.45) per share. Northland Securities also issued estimates for Amprius Technologies’ Q1 2027 earnings at $0.04 EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at $0.05 EPS, Q4 2027 earnings at $0.05 EPS and FY2027 earnings at $0.18 EPS.

Amprius Technologies (NYSE:AMPXGet Free Report) last issued its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $25.23 million for the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies had a negative return on equity of 25.77% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS.

A number of other equities analysts have also recently weighed in on the company. Craig Hallum upped their price target on Amprius Technologies from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Friday. Roth Mkm reaffirmed a “buy” rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research note on Friday. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a report on Friday. Needham & Company LLC assumed coverage on shares of Amprius Technologies in a research report on Thursday, January 29th. They issued a “buy” rating and a $20.00 price objective for the company. Finally, B. Riley Financial raised their price objective on Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research note on Monday. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Get Our Latest Stock Analysis on Amprius Technologies

Amprius Technologies Price Performance

Shares of NYSE AMPX opened at $17.72 on Tuesday. The company has a market capitalization of $2.31 billion, a price-to-earnings ratio of -52.10 and a beta of 3.04. Amprius Technologies has a 1-year low of $1.70 and a 1-year high of $17.74. The business has a 50-day moving average of $11.07 and a 200-day moving average of $10.82.

Insider Activity

In other news, CTO Constantin Ionel Stefan sold 25,366 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the sale, the chief technology officer owned 723,330 shares in the company, valued at approximately $7,349,032.80. This represents a 3.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kang Sun sold 61,251 shares of the stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director directly owned 1,342,400 shares in the company, valued at $13,638,784. The trade was a 4.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,392,269 shares of company stock valued at $26,384,359 in the last three months. Insiders own 12.80% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Alberta Investment Management Corp bought a new position in Amprius Technologies during the 4th quarter worth approximately $1,001,000. Vident Advisory LLC bought a new stake in shares of Amprius Technologies in the 4th quarter valued at approximately $107,000. Summit Securities Group LLC bought a new stake in shares of Amprius Technologies in the 4th quarter valued at approximately $54,000. Numerai GP LLC raised its position in shares of Amprius Technologies by 29.1% during the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock valued at $759,000 after acquiring an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. raised its position in shares of Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock valued at $3,589,000 after acquiring an additional 267,385 shares in the last quarter. Institutional investors own 5.04% of the company’s stock.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Multiple analysts raised ratings and price targets (buy ratings and targets in the low-$20s), signaling more institutional conviction and a higher consensus valuation. Read More.
  • Positive Sentiment: MarketBeat highlights record trading volume tied to the Q4 release — volume-backed breakouts increase the odds the rally continues because they show real market conviction. Read More.
  • Positive Sentiment: Q4 results showed record revenue growth and the company reported its first positive adjusted quarterly EBITDA; management cited expanding adoption of its 2nd‑gen silicon‑anode batteries and new commercial/defense wins. Read More.
  • Positive Sentiment: IBD upgraded AMPX, adding a reputable media/ratings endorsement that can attract momentum investors and retail flows. Read More.
  • Neutral Sentiment: Analyst fair‑value estimates have moved higher (consensus and some firms into the ~$20–22 range), but coverage remains relatively light — helpful for upside if coverage expands, yet still leaves forecasts dispersed. Read More.
  • Negative Sentiment: Despite progress, Amprius remains unprofitable on a GAAP basis and guidance/consensus EPS still negative for the year; valuation and momentum make the stock volatile (high beta), so downside risk exists if growth or NDAA/compliance milestones slip. Read More.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Further Reading

Earnings History and Estimates for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.